Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors - Vogt,T.; Hafner,C.; Bross,K.; Bataille,F.; Jauch,K.W.; Berand,A. (Cancer, 2003)